Ferumoxytol-enhanced MRI of retroplacental clear space disruption in placenta accreta spectrum

This publication has 34 references indexed in Scilit:

• Antenatal diagnosis of placenta accreta spectrum (PAS) disorders
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
• A comparison of recent guidelines in the diagnosis and management of placenta accreta spectrum disorders
  Best Practice & Research Clinical Obstetrics & Gynaecology, 2021
• FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders,
  International Journal of Gynecology & Obstetrics, 2019
• Pre-clinical magnetic resonance imaging of retroplacental clear space throughout gestation
  Placenta, 2019
• Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders
  American Journal of Obstetrics and Gynecology, 2018
• Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta
  Placenta, 2017
• Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI – useful features for differentiating placenta percreta from placenta accreta
  European Radiology, 2017
• The gravid uterus: MR imaging and reporting of abnormal placentation
  Abdominal Radiology, 2016
• Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach
  American Journal of Obstetrics and Gynecology, 2015
• Emerging applications for ferumoxytol as a contrast agent in MRI
  Journal of Magnetic Resonance Imaging, 2014